Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Candel Therapeutics Inc
(NQ:
CADL
)
5.050
-0.090 (-1.75%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Candel Therapeutics Inc
< Previous
1
2
3
4
Next >
After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study
April 04, 2024
Candel Therapeutics updates phase 2 trial results for CAN-2409 and valacyclovir in pancreatic cancer treatment, revealing prolonged survival rates up to 28.8 months versus standard therapy's 12.5...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!
Via
InvestorPlace
Micro-Cap Cancer Focused Candel Therapeutics Highlights Encouraging Data From Brain Tumor Immunotherapy
April 01, 2024
Data from Candel Therapeutics on CAN-3110, a promising viral immunotherapy for recurrent high-grade glioma. Discover survival rates and potential advancements in cancer treatment.
Via
Benzinga
Recap: Candel Therapeutics Q4 Earnings
March 28, 2024
Via
Benzinga
Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies
February 15, 2024
--News Direct--
Via
News Direct
Recap: Candel Therapeutics Q3 Earnings
November 09, 2023
Via
Benzinga
Candel Therapeutics: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
CADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023
March 28, 2024
CADL stock results show that Candel Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors
March 15, 2024
--News Direct--
Via
News Direct
Moving Fast: Candel’s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
February 28, 2024
--News Direct--
Via
News Direct
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via
Benzinga
Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies
February 13, 2024
A clinical-stage biopharmaceutical company looks forward to the year ahead with several promising developments in motion.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 18, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 13, 2023
Via
Benzinga
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 12, 2023
Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 12, 2023
Via
Benzinga
US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November
December 12, 2023
U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 12, 2023
Via
Benzinga
Why Is Cancer Player Candel Therapeutics Stock Trading Higher Today?
November 06, 2023
Candel Therapeutics Inc (NASDAQ: CADL) released initial interim survival and immunological biomarker data from the ongoing phase 2 trial of CAN-2409 plus valacyclovir (prodrug) together with standard...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
Via
Benzinga
Candel Therapeutics Reveals Early Survival Data From Lung Cancer Trial
September 26, 2023
Candel Therapeutics Inc (NASDAQ: CADL) announced updated activity data from its ongoing, open-label, phase 2 trial of CAN-2409 plus valacyclovir in combination with continued immune checkpoint...
Via
Benzinga
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 21, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Candel Therapeutics Says One Dose Of CAN-3110 Shows Encouraging Responses In A Type Of Brain Cancer
May 19, 2023
Candel Therapeutics Inc (NASDAQ: CADL) announced new data from an ongoing phase 1 trial of its herpes simplex virus-1 (HSV-1) replication-competent viral immunotherapy candidate, CAN-3110, in patients...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 21, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.